News

Continuous glucose monitoring devices could overstate blood sugar levels, with a study revealing inconsistencies in readings ...
The FDA has cleared the Dexcom G7 15 Day continuous glucose monitoring system for individuals 18 years and older with ...
has cleared the Dexcom G7 15 Day continuous glucose monitoring (CGM) system for individuals 18 years and older with diabetes. The Dexcom G7 15 Day CGM system is a wearable sensor that continuously ...
The Food and Drug Administration has cleared diabetes-management firm DexCom's new continuous glucose monitoring (CGM) system ...
Dexcom has announced that the U.S. Food and Drug Administration has cleared its G7 15 Day Continuous Glucose Monitoring ...
DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, announced today the FDA has cleared the Dexcom G7 15 Day ...
The new sensor — expected to launch in the second half of 2025 — will provide easier diabetes management for eligible users.
What to do: Check your alert settings and refer to your device's manual to ensure the alerts are working as expected. Some people who use continuous glucose monitors have reported not receiving or ...
Among patients with type-2 diabetes (T2D) requiring insulin therapy, automated insulin delivery (AID) resulted in a greater ...
new continuous glucose monitoring (CGM) system. The San Diego, Calif.-based firm said Thursday that its Dexcom G7 15 Day system had been approved by the FDA to treat people 18 and older with diabetes.